J. Spindler, I. Pfister, A. Weinberger, J. Garweg
Prevalence of Polypoidal Choroidal Vasculopathy Beyond Recalcitrant Macular Neovasculopathies in a European AMD Cohort and Therapeutic Response to Brolucizumab
14.2.2026, Journal of Clinical Medicine, J. Clin. Med. 2026, 15(4), 1492; https://doi.org/10.3390/jcm15041492
A. Tillmann, R. Stillenmunkes, J. Garweg, J. Cattaneo, N. Bartolomeo, G. Grimaldi, T. Spitznagel, E. Figueiredo, A. Ambresin, M. Menghini, G. Somfai, S. Zweifel, J. Froehlich, D. Artemiev, A. Ebneter, K. Hatz, A. Weinberger, I. Pfister, C. Schild, C. Eandi, M. Munk & Swiss Retina Research Network
One-Year Outcomes of Faricimab in Treatment-Naïve Neovascular Age-Related Macular Degeneration: A Swiss Retina Research Network Report
17.10.2025, Ophthalmology and Therapy, Ophthalmol Ther. 2025; 14:3079-3091. https://doi.org/10.1007/s40123-025-01252-6
G. Grimaldi, A. Ambresin, I. Pfister, C. Schild, C. Plasencia, K. Hatz, R. Stillenmunkes, M. Munk, A. Paris, M. Menghini, D. Artemiev, A. Ebneter, J. Cattaneo, E. Figueiredo, C. Eandi, J. Froehlich, N. Feltgen, T. Spitznagel, G. Somfai, M. Cozzi, S. Zweifel, A. Weinberger, J. Garweg
One-Year Outcomes after Switching to Faricimab in Eyes with Pretreated Neovascular Age-Related Macular Degeneration
A Swiss Retina Research Network Report
1.9.2025, Ophthalmology Retina, 2025 Mar 24:S2468-6530(25)00124-1. doi: 10.1016/j.oret.2025.03.015. Epub ahead of print.
I. Pfister, C. Schild, J. Garweg
Predicting long-term functional anti-VEGF treatment outcomes in neovascular AMD in a real-world setting
25.11.2024, PLOS One, 2024 Nov 25;19(11):e0314167. doi: 10.1371/journal.pone.0314167
F. Turgut, G. Somfai, C. Tappeiner, K. Hatz, I. Mantel, A. Ambresin, G. Donati, V. Guignard, D. Nagyova, I. Pfister, C. Schild, J. Garweg
Intravitreal Dexamethasone Implant in Anti-Vascular Endothelial Growth Factor Pretreated Diabetic Macular Edema-A Swiss Cohort Study
19.9.2024, Pharmaceuticals, 2024 Sep 19;17(9):1235. doi: 10.3390/ph17091235
A. Bograd, I. Himmel, I. Pfister, T. Seiler, B. Frueh, C. Tappeiner
Comparison of corneal measurements in keratoconus eyes with two swept-source-optical coherence tomography devices and a Scheimpflug device
1.3.2024, Graefe’s archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv für klinische und experimentelle Ophthalmologie, 2024 Mar;262(3):891-901. doi: 10.1007/s00417-023-06219-6. Epub 2023 Sep 9. Erratum in: Graefes Arch Clin Exp Ophthalmol. 2024;262(3):1009. doi: 10.1007/s00417-023-06258-z
M. Pietzuch, I. Mantel, A. Ambresin, C. Tappeiner, D. Nagyova, G. Donati, I. Pfister, C. Schild, J. Garweg
Intravitreal Dexamethasone as a Rescue for Anti-Vascular Endothelial Growth Factor Therapy in Neovascular Age-Related Macular Degeneration with Persistent Disease Activity and High Treatment Demand
20.12.2023, Journal of ocular pharmacology and therapeutics: the official journal of the Association for Ocular Pharmacology and Therapeutics, 2024;40(6): 361-369. doi: 10.1089/jop.2023.0105
L. Saucedo, I. Pfister, C. Schild, J. Garweg
Association of inflammation-related markers and diabetic retinopathy severity in the aqueous humor, but not serum of type 2 diabetic patients
26.10.2023, PLOS One, 2023;18(10):e0293139. Published 2023 Oct 26. doi:10.1371/journal.pone.0293139
J. Garweg, J. Keiper, I. Pfister, C. Schild
Functional Outcomes of Brolucizumab-Induced Intraocular Inflammation Involving the Posterior Segment-A Meta-Analysis and Systematic Review
14.7.2023, Journal of Clinical Medicine, 2023, 12, 4671. https://doi.org/10.3390/jcm12144671
R. Garweg, I. Pfister, C. Schild, M. Halberstadt, K. Straessle, S. Anastasi, J. Garweg
IOP-lowering and drug-sparing effects of trabectome surgery with or without cyclodialysis ab interno
5.5.2023, Graefe’s archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv für klinische und experimentelle Ophthalmologie, 2023 May 5. doi: 10.1007/s00417-023-06063-8. Epub ahead of print. PMID: 37145333
C. Hänsli, C. Schild, I. Pfister, J. Garweg
Brolucizumab in Pretreated Neovascular Age-Related Macular Degeneration: Case Series, Systematic Review, and Meta-Analysis
17.3.2023, Life, 2023; 13(3):814. https://doi.org/10.3390/life13030814
L. Saucedo, I. Pfister, C. Schild, S. Zandi, J. Garweg
Aqueous Humor Apolipoprotein Concentration and Severity of Diabetic Retinopathy in Type 2 Diabetes.
10.11.2022, Mediators of Inflammation, 2022:2406322. doi: 10.1155/2022/2406322. PMID: 36405993; PMCID: PMC9671721.
J. Garweg, F. Kieffer, L. Mandelbrot, F. Peyron, M. Wallon
Long-Term Outcomes in Children with Congenital Toxoplasmosis-A Systematic Review.
15.10.2022, Pathogens, 11(10):1187. doi: 10.3390/pathogens11101187. PMID: 36297244; PMCID: PMC9610672.
J. Wons, I. Pfister, S. Anastasi, S. Steinhauer, S. Niderprim, J. Garweg
Functional Outcome After Macular Hole Surgery: Comparison of Standard Perimetry with Microperimetry
11.7.2022, Clinical ophthalmology (Auckland, N.Z.), 16:2235-2243. doi: 10.2147/OPTH.S367431. PMID: 35844664; PMCID: PMC9286483
A. Bograd, D. Fuchs, J. Bächtiger, I. Pfister, J. Spindler, F. Hoogewoud, K. Gugleta, C. Böni, Y. Guex-Crosier, J. Garweg, C. Tappeiner
Long-term Efficacy of TNF-alpha Inhibitors on Persistent Uveitic Macular Edema: A Swiss Multicenter Cohort Study.
19.5.2022, Ocular immunology and inflammation, 1-8. doi: 10.1080/09273948.2022.2075761. Epub ahead of print. PMID: 35588311
L. Saucedo, I. Pfister, S. Zandi, C. Gerhardt, J. Garweg
Ocular TGF-β, Matrix Metalloproteinases, and TIMP-1 Increase with the Development and Progression of Diabetic Retinopathy in Type 2 Diabetes Mellitus.
25.6.2021, Mediators of Inflammation, 2021:9811361. doi: 10.1155/2021/9811361. PMID: 34257518; PMCID: PMC8257377.
C. Hänsli, I. Pfister, J. Garweg
Switching to Brolucizumab in Neovascular Age-Related Macular Degeneration Incompletely Responsive to Ranibizumab or Aflibercept: Real-Life 6 Month Outcomes.
17.6.2021, Journal of Clinical Medicine, 10(12):2666. doi: 10.3390/jcm10122666. PMID: 34204266; PMCID: PMC8235134.
A. Baston, C. Gerhardt, S. Zandi, J. Garweg
Visual Outcome after Intravitreal Anti-VEGF Therapy for Macular Neovascularisation Secondary to Sorsby’s Fundus Dystrophy: A Systematic Review.
20.5.2021, Journal of Clinical Medicine, 10(11):2433. doi: 10.3390/jcm10112433. PMID: 34070857; PMCID: PMC8198854.
J. Wons, N. Mihic, I. Pfister, S. Anastasi, J. Garweg, M. Halberstadt
Effect of Preoperative Intraocular Pressure in Patients with and without Intolerance to Their IOP-Lowering Medication on the Outcome of Trabectome Surgery.
6.5.2021, Clinical ophthalmology (Auckland, N.Z.), 15:1851-1860. doi: 10.2147/OPTH.S303603. PMID: 33986587; PMCID: PMC8110264.
J. Garweg, C. Gerhardt
Disease stability and extended dosing under anti-VEGF treatment of exudative age-related macular degeneration (AMD) – a meta-analysis.
2.2.2021, Graefe’s archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv für klinische und experimentelle Ophthalmologie, 2021 Aug;259(8):2181-2192. doi: 10.1007/s00417-020-05048-1. Epub ; PMID: 33528645; PMCID: PMC8352813.
